United States · FDA National Drug Code directory
Linezolid
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63323-713_d151d608-d9c5-4b78-b99b-f0cb53e6c439
- Product NDC
- 63323-713
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Linezolid
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20150622
- Source listing expiry
- 20261231
Source-listed ingredients
- LINEZOLID — 2 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 BAG in 1 CASE (63323-713-13) / 300 mL in 1 BAG (63323-713-03) · 63323-713-13
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →